Condition 1: Pregnancy related lumbo pelvic pain. Condition 2: Functional disability. Pelvic and perineal pain Other specified pregnancy related conditions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy pregnant women in 18 -22 week of pregnancy Age 20-35 years old Nolyparus No history of abortion Normal first & the second pregnancy screening results Received at least the first shot of covid-19 vaccine Being diagnosed with lumbopelvic pain by a gynecologist
Exclusion criteria
Exclusion criteria: Any spinal phatology Neoplastic process Infections Vascular diseases Endocrine & metabolic diseases Being under treatment & giving pain killers for lumbopelvic pain A history of lumbar spine surgery Uterus & vaginal bleeding Any contraindication of exercise in pregnancy regarding the Royal College of Obstetrician & Gynecologists guidelines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain; Lumbo pelvic pain. Timepoint: At the baseline ( before interventions ), weeks 34 & 38 of pregnancy(after interventions & follow up). Method of measurement: Visual Analogue Scale(VAS).;Functional Disability. Timepoint: At the baseline ( before interventions ), weeks 34 & 38 of pregnancy(after interventions & follow up). Method of measurement: Oswestry Disability Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Selective Functional Movement Assessment(SFMA). Timepoint: At the baseline ( before interventions), weeks 34& 38 of pregnancy ( After interventions & follow up ). Method of measurement: Regarding to the Selective Functional Movement Assessments (SFMA) scores presented by Gray Cook.;Physiologic Parameters. Timepoint: At the baseline ( before interventions), weeks 34& 38 of pregnancy ( After interventions & follow up ). Method of measurement: Blood Lab Exams.;Gait parameters. Timepoint: At the baseline ( before interventions), weeks 34 & 38 of pregnancy ( After interventions & follow up ). Method of measurement: Kinovea Soft ware.;Posture. Timepoint: At the baseline ( before interventions), weeks 34& 38 of pregnancy ( After interventions & follow up ). Method of measurement: Kinovea Soft ware. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kharazmi University